TherapeuticsMD, Inc. (TXMD)
NMS · Healthcare · Drug Manufacturers - Specialty & Generic
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 952K | 784K | 893K | 724K |
| Gross Profit | ||||
| Operating Income | -695K | -830K | -1.5M | -723K |
| Net Income | 551K | 152K | -619K | 95K |
| Diluted EPS | $0.05 | $0.01 | $nan | $0.01 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 70.0M | 1.3M | 1.8M | 3.0M |
| Gross Profit | 68.6M | 1.3M | ||
| Operating Income | 10.7M | -8.5M | -4.8M | -4.2M |
| Net Income | 112.0M | -10.3M | -2.2M | -569K |
| Diluted EPS | $11.96 | $-0.98 | $-0.19 | $-0.05 |